Dr. Raluca Vrabie, MD

Dr. Vrabie practices at New Hyde Park Endoscopy in Lake Success, New York.

Dr. Vrabie's NPI, 1770672750, was assigned on October 11, 2006. Dr. Vrabie graduated from Icahn School of Medicine at Mount Sinai in 2003. Dr. Vrabie holds New York license 233971.

Dr. Vrabie's primary practice is New Hyde Park Endoscopy, at 1991 Marcus Avenue, Lake Success, NY 11042. The practice phone is (317) 796-7565.

Dr. Vrabie's primary practice is New Hyde Park Endoscopy in Lake Success, New York. Dr. Vrabie is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Vrabie to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vrabie practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Vrabie's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Vrabie is licensed in New York.

CMS data shows 320 Medicare services from Dr. Vrabie across 10 procedure codes in 2024, for 245 Medicare patients. Medicare paid $38,953 for them.

CMS counts 245 Medicare patients who saw Dr. Vrabie in 2024. The largest group is 75 to 84, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vrabie's median patient age at 59, with 58% women.

In 2024, Dr. Vrabie wrote 300 Medicare Part D claims for 106 patients. 71% of them were for generic drugs. CMS names the drug for 179 of them, across 9 drugs with 11 or more claims each, at $443,374 in total drug cost. In 2023, CMS named 128 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vrabie for performance year 2024, reported through an alternative payment model (APM). Dr. Vrabie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vrabie as offering telehealth. CMS counts 37 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Vrabie, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Vrabie, published from 2020 to 2022. Dr. Vrabie's most frequent co-authors are Raymond Keith Cross, MD, Matthew Joseph Demaria, DO and David Moshe Friedel, MD.

Dmand AI links Dr. Vrabie to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases.

CMS Open Payments shows 20 general payments to Dr. Vrabie from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $270.

Dr. Vrabie graduated from Icahn School of Medicine at Mount Sinai in 2003.